Table 1. Clinical characteristics between NSTE-ACS and STEMI groups.
| Total (n = 204) | NSTE-ACS (n = 101) | STEMI (n = 103) | P value | |
|---|---|---|---|---|
| Male (%) | 139 (68.1) | 61 (60.4) | 78 (75.7) | 0.024 |
| Age (years) | 69.6 ± 11.0 | 70.0 ± 10.7 | 69.1 ± 11.2 | 0.553 |
| BMI (kg/m2) | 23.8 ± 3.7 | 23.8 ± 3.9 | 23.7 ± 3.4 | 0.891 |
| AC (cm) | 87.5 ± 9.1 | 86.8 ± 9.5 | 88.1 ± 8.7 | 0.335 |
| Diabetes (%) | 86 (42.2) | 42 (41.6) | 44 (42.7) | 0.888 |
| Hypertension (%) | 154 (75.5) | 81 (80.2) | 73 (70.9) | 0.144 |
| Dyslipidemia (%) | 149 (73.0) | 77 (76.2) | 72 (69.9) | 0.346 |
| Current smoking (%) | 50 (24.5) | 14 (13.9) | 36 (35.0) | 0.001 |
| Family history (%) | 53 (26.0) | 30 (29.7) | 23 (22.3) | 0.265 |
| CKD (%) | 62 (30.4) | 29 (28.7) | 33 (32.0) | 0.65 |
| Previous MI (%) | 8 (3.9) | 2 (2.0) | 6 (5.8) | 0.279 |
| Previous stroke (%) | 19 (9.3) | 8 (7.9) | 11 (10.7) | 0.631 |
| PAD (%) | 15 (7.4) | 8 (7.9) | 7 (6.8) | 0.795 |
| Past GD diseases | 12 (5.9) | 5 (5.0) | 7 (6.8) | 0.768 |
| Current GD diseases | 7 (3.4) | 5 (5.0) | 2 (1.9) | 0.277 |
| Proton-pump inhibitors | 30 (14.7) | 16 (15.8) | 14 (13.6) | 0.696 |
| hs-CRP (mg/dl) | 0.04 (0.02–0.07) | 0.04 (0.02–0.06) | 0.04 (0.02–0.08) | 0.901 |
| H. pylori IgG (%) | 90 (44.1) | 37 (36.6) | 53 (51.5) | 0.036 |
| IL-1 beta-511 C/C (%) | 60 (29.7) | 34 (33.7) | 26 (25.7) | 0.281 |
| IL-1 beta-511 C/T (%) | 88 (43.6) | 38 (37.6) | 50 (49.5) | 0.118 |
| IL-1 beta-511 T/T (%) | 54 (26.7) | 29 (28.7) | 25 (24.8) | 0.634 |
| IL-1RN *2 allele (%) | 27 (13.5) | 16 (16.2) | 11 (10.9) | 0.306 |
| IL-1 polymorphisms | 146 (72.3) | 70 (69.3) | 76 (75.2) | 0.432 |
Abbreviations: NSTE-ACS, Non ST segment elevation acute coronary syndrome; STEMI, ST segment elevation acute myocardial infarction; BMI, body mass index; AC, abdominal circumference; CKD, chronic kidney disease; MI, myocardial infarction; PAD, peripheral arterial disease; GD, gastroduodenal; hs-CRP, high-sensitivity C-reactive protein; H. pylori, Helicobacter pylori; IgG, immunoglobulin; IL-1, interleukin-1; IL-1RN, interleukin-1 antagonist